Domvanalimab and Zimberelimab in Advanced Liver Cancers
Clinical trial NCT05724563 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05724563
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-12
- Primary completion
- 2027-12-31
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.